Classification of and Risk Factors for Estrogen Deprivation Pain Syndromes Related to Aromatase Inhibitor Treatments in Women With Breast Cancer: A Prospective Multicenter Cohort Study

Abstract Aromatase inhibitors (AIs) are the first-line treatment in women with breast cancer for total estrogen depletion. Half the treated women may develop pain, and this condition may therefore be seen as a clinical model of pain related to estrogen deprivation. In this prospective multicenter st...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The journal of pain 2014-03, Vol.15 (3), p.293-303
Hauptverfasser:	Laroche, Francoise, Coste, Joël, Medkour, Terkia, Cottu, Paul Henri, Pierga, Jean-Yves, Lotz, Jean-Pierre, Beerblock, Karine, Tournigand, Christophe, Declèves, Xavier, de Cremoux, Patricia, Bouhassira, Didier, Perrot, Serge
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Analgesics - therapeutic use Anesthesia & Perioperative Care aromatase inhibitors Aromatase Inhibitors - adverse effects Aromatase Inhibitors - therapeutic use Arthralgia - chemically induced Arthralgia - diagnosis Arthralgia - physiopathology arthritis Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - physiopathology estrogen deprivation Estrogens Female Follow-Up Studies Humans Neuralgia - chemically induced Neuralgia - diagnosis Neuralgia - physiopathology pain Pain - chemically induced Pain - diagnosis Pain - physiopathology Pain Medicine Prognosis Prospective Studies Risk Factors Syndrome Tendinopathy - chemically induced Tendinopathy - diagnosis Tendinopathy - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!